What to expect as FDA advisory panel debates Pfizer COVID booster shots

  • 📰 ABC
  • ⏱ Reading Time:
  • 63 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

The FDA's independent advisory committee is convening to review data submitted by Pfizer and discuss whether a booster dose is safe enough for widespread use and whether it's necessary and effective at improving protection levels against COVID-19.

Two top FDA officials who are leaving the agency later this year publicly waded into the debate on Monday, splitting from the agency and arguing in a scientific journal that it was too soon to give booster shots to the general public since theBoth are scheduled to attend Friday's discussion. One of them, the director of the agency's office of vaccines research and review, is supposed to give an overarching introduction of the topic for the FDA in the beginning of the day.

Also joining Friday's meeting is the head of Israel's public health services, Dr. Sharon Alroy Preis, who is set to present data on booster protection against COVID infection and severe disease.In a review of Pfizer's data, also released Wednesday, the FDA appeared to be noncommittal on the necessity for boosters.

"There are many po­ten­tial­ly rel­e­vant stud­ies, but FDA has not in­de­pen­dent­ly re­viewed or ver­i­fied the un­der­ly­ing da­ta or their con­clu­sions," the agency wrote in its briefing. Naming no one -- but nodding to those lingering concerns -- Pfizer's CEO Albert Bourla penned an open letter on Thursday making the case for booster shots.

"This week we are approaching another pivotal moment in our ongoing fight against the virus," Bourla writes of Friday's FDA advisory committee."Since the start of this pandemic, Pfizer and BioNTech have pledged to follow the science and keep people informed about our progress to help bring an end to this global health crisis. We have stayed true to our commitment of full transparency without selectively cherry-picking data.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Great, we haven't even finished the first wave of hesitancy. They should of let our own DRs handle this booster when they Mandate it. I trust my Doc. Get it?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 471. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Source: Forbes - 🏆 394. / 53 Read more »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection أرجو منكم الدعم لقناتي بجام و برتاج و أبوني بدعمكم أستمر وينكم يا أحلي أصدقاء في التويتر هذا رابط قناتي على اليوتيوب 😍🙏👍👇👇👇👇👇👇👇👇👇 تونس فلسطين قطر2022 الجزائر I’m buy BabyDoge BabyDogeCoin and I will milliners in Q1 - 2022 BABYDOGEBILLIONAIRE
Source: Forbes - 🏆 394. / 53 Read more »

Pfizer says third COVID shot gives antibodies in threefold, likely can handle Delta variantThe FDA on Wednesday posted much of the evidence from Pfizer on booster shots to be considered by its advisory panel on Friday. If I trust anyone with my life…it’s Pfizer and the FDA. 🙄
Source: Newsweek - 🏆 468. / 52 Read more »

FDA Says Covid-19 Vaccines Remain Effective Without BoostersThe Food and Drug Administration said vaccines cleared in the U.S. currently provide protection against severe disease and death from Covid-19, potentially complicating the Biden administration’s deliberations over the need for booster shots We don’t buy bitcoin We earn bitcoin From Mining I'm ready to show 10 lucky people on how to earn 0.1 ($4,845) and more daily! No referral No withdrawal fees Interested people only Kindly send us a DM We need boosters to keep the window of opportunity open longer…
Source: WSJ - 🏆 98. / 63 Read more »

FDA strikes cautious tone ahead of Pfizer booster meetingData published Wednesday from the agency adds to the debate over whether an extra dose of the vaccine is warranted. I like the words 'against severe'. Now l would like to see the numbers, but not words. Just wondering why only 1 vaccine was approved for regular usage in US and the name of it was changed. Where are the data, and where are the proves of absence of side effects in a long run?
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster ProposalThe Biden administration has planned to launch a booster shot campaign for the general public as early as next week.
Source: HuffPostWomen - 🏆 27. / 68 Read more »